8-K Filing

Company

REGENERON PHARMACEUTICALS, INC.

Filed

June 19, 2019

Period of Report

June 14, 2019

Accession Number

0000930413-19-001896

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →